Marin Oncology Associates
Greenbrae, California, United States
Cancer treatment center in Larkspur, California
1350 S Eliseo Dr, Greenbrae, CA 94904
About Marin Oncology Associates
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Celgene
4
Clinical Trials at Marin Oncology Associates
During the past decade, Marin Oncology Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)
2013-04-26
2023-06-30
Active, not recruiting
216
Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
2013-01-07
2022-05-13
Completed
559
Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma)
2013-11-21
2022-01-26
Completed
358
Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting
2014-05-29
2025-05-24
Active, not recruiting
186
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Marin Oncology Associates
According to Clinical.Site data, the most researched conditions in "Marin Oncology Associates" are
"Multiple Myeloma" (2 trials), "Lymphoma, Non-Hodgkin" (1 trials) and "Myelodysplastic Syndrome" (1 trials). Many other conditions were trialed in "Marin Oncology Associates" in a lesser frequency.
Clinical Trials Intervention Types at Marin Oncology Associates
Most popular intervention types in "Marin Oncology Associates" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Dexamethasone" (2 trials), "Placebo" (2 trials), "Pomalidomide" (2 trials), "Best Supportiv Care (BSC)" (1 trials) and "Bortezomib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Marin Oncology Associates
The vast majority of trials in "Marin Oncology Associates" are
4 trials for "All" genders.
Clinical Trials Status at Marin Oncology Associates
Currently, there are NaN active trials in "Marin Oncology Associates".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Marin Oncology Associates,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Marin Oncology Associates, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".